ISRCTN15591075已完成未知
A preliminary safety and efficacy evaluation of direct intrapancreatic tail delivery of autologous bone marrow-derived cells in Egyptian patients with type 1 diabetes mellitus
Wadi EL-Neel hospital (JCI)0 个研究点目标入组 3 人开始时间: 2017年5月2日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 3
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Males and females aged between 2 to 30 years of age
- •2. Confirmed T1D based on the American Diabetes association (ADA) 2015 criteria for diagnosis
- •3. Body mass index (BMI) of = 29.9
排除标准
- •1. Active infections
- •2. Any chronic or acute illness
- •3. Antibodies to hepatitis B surface antigen
- •4. Hepatitis C
- •5. Human immunodeficiency virus or evidence of diabetic complications at baseline
- •6. Pregnant, are breast-feeding or intend to become pregnant during the study
- •7. Clinically relevant uncontrolled medical conditions not associated with diabetes (such as hematologic, renal, hepatic, neurologic, cardiac and respiratory conditions)
- •8. Evidence of active malignancy or a prior history of active malignancy
研究者
相似试验
进行中（未招募）
2 期
PMX-DHP for COVID-19JPRN-jRCTs032200131Izumi Shinnyuu30
已完成
不适用
To determine the safety and effectiveness of Dandruff ControlOil Shots in dandruff reduction in Healthy Adult HumanSubjects with Dandruff on the scalpCTRI/2022/04/041701Brillare Science Private Limited16
进行中（未招募）
不适用
A study of DoTiNurad aiming to treat hyperuricemia with CKDPatients with hyperuricemia whose renal function is in the GFR range of G1 to G4JPRN-jRCTs061210079Wada Jun100
已完成
不适用
To evaluate the efficacy and safety of the newly developed low-intensity ultrasound-transcutaneous nerve stimulation combined therapy for knee pain with osteoarthritis for 20 minutes, 3 times a day (more than 10 times a week) for a total of 8 weeks Single-institution, double-blind, randomized, parallel design, study-based clinical trialsKCT0003883Chonbuk National University Hospital40
已完成
4 期
Comparison of efficacy and safety of Drotaverine Versus Mebeverine in Irritable Bowel SyndromeCTRI/2017/11/010529Walter Bushnell Pvt Ltd200